Galindo, Juliano D.

HRN: 29-08-61  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2026
CEFTAZIDIME 1GM (VIAL)
06/02/2026
06/08/2026
IV
2gms
Q8
Pneumonia
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines